According to a new market report published by Lucintel, the future of the antibody production market looks promising with opportunities in pharmaceutical & biotechnology companies and research laboratories. The global antibody production market is expected to grow with a CAGR of 14% from 2020 to 2025. The major drivers for this market are rise in adoption of targeted immunotherapy and increasing R&D activities in the biopharmaceutical & biotechnology industries for the production of antibody therapeutics.
The antibody production comprises products that are required during the different stages of bioprocessing of antibodies, such as upstream processing, downstream
To download report brochure, please go to https://www.lucintel.com/antibody-production-market.aspx and click "download brochure" tab from the menu
processing and filtration. In this market, polyclonal antibody, monoclonal antibody, murine, chimeric, and humanized are the major types. Lucintel forecasts that monoclonal antibody will remain the largest type segment over the forecast period due to increasing investment in monoclonal antibody research and a large number of antibody-based product launches.
Within this market, pharmaceutical and biotechnology companies will remain the largest end use segment over the forecast period due to the increasing demand of antibodies in various applications of the pharmaceutical and biotechnology production process.
North America will remain the largest region over the forecast period due to a large number of pharmaceutical and biotechnology companies in the region, the presence of a well-established healthcare market, and growth in the pharmaceutical industry.
GE Healthcare, Thermo Fisher Scientific, Sartorius, Merck, Pall, Sigma-Aldrich, Eppendorf, Cellab, INTEGRA Biosciences, and FiberCell System are among the major suppliers in the global antibody production market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global antibody production market by type, process, end use, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Antibody Production Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global antibody production market by type, process, end use, and region as follows:
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Polyclonal Antibody
Monoclonal Antibody
Murine
Chimeric
Humanized
By Process [Value ($ Million) shipment analysis for 2014 – 2025]:
Upstream Processing
Bioreactors
Consumables
Media
Buffers and Reagents
Downstream Processing
Chromatography Systems
Chromatography Resins
Filtration
Filtration Systems
Filtration Consumables and Accessories
By End Use [Value ($ Million) shipment analysis for 2014 – 2025]:
Pharmaceutical and Biotechnology Companies
Research Laboratories
Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Spain
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.